Vector Laboratories announces merger with Absolute Biotech, expanding capabilities as a critical component manufacturer for life science customers
May 15, 2024•over 1 year ago
Acquiring Company
Vector Labs
Acquired Company
Absolute Biotech
BiotechnologyManufacturing
Description
Vector Laboratories, a manufacturing partner of reagents and critical components for life sciences tools, diagnostics, and clinical-stage biotherapeutics, has announced its intention to merge with Absolute Biotech, a unified company of multiple antibody-centric brands, to better serve life science customers. The merger solidifies Vector Laboratories' position as a comprehensive supplier of both custom-engineered and catalog antibodies and sophisticated bioconjugation linkers, helping to reduce development time and internal resource commitments for biopharma customers and channel partners.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed